NNC6022-0001

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC6022-0001, covering 2025-04-16 to 2025-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People [Phase 1]